Abstract

Background: In the last decade, standard treatment of patients with breast cancer and metastases in the sentinel nodes has been a completion of axillary node clearance. However, several trials have demonstrated that, among certain groups of patients, axillary dissection might be over-treatment as no surgical intervention leads to similar results. This study aims to evaluate the applicability of ACOSOG Z0011 trial (Z11) results for our patient population in Central Europe, analysing DFS, OS and locoregional recurrence.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call